早期复发性复发性多发性硬化症患者的绝望感
Susana Sainz de la Maza1, Jorge Maurino2, Tamara Castillo-Triviño3
1Department of Neurology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Patient preference and adherence
|June 20, 2023
概括
在早期复发性缓解性多发性硬化症 (RRMS) 中,绝望是常见的,影响超过65%的患者. 诸如老年,抑郁和疾病感知等因素与这种状态有关,影响了对疾病的适应.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 复发性复发性多发性硬化症 (RRMS) 是年轻人残疾的主要原因.
- 绝望是众所周知的抑郁和自杀的危险因素.
- 有限的数据存在于早期RRMS患者的绝望.
研究的目的:
- 评估早期RRMS状态绝望的流行情况.
- 为了确定与这一群体的绝望相关的因素.
主要方法:
- 一项多中心,非干预性研究包括189名成人RRMS患者,疾病持续时间≤3年和EDSS 0-5.5.5.
- 州的绝望度是使用州-海峡绝望度表 (STHS) 来衡量的.
- 多变量逻辑回归分析了患者特征与绝望之间的关联.
主要成果:
- 65.6%的患者报告中度至严重的绝望.
- 绝望与老年相关 (p=0.035),抑郁症状 (p<0.001),威胁疾病感知 (p=0.001) 和工作场所障碍 (p=0.029).
- 这些关联在经过调整以考虑混因素后仍然显著.
结论:
- 在早期的RRMS中,无论身体残疾如何,绝望是普遍存在的.
- 识别相关因素对于制定预防策略至关重要.
- 这些策略可以帮助患者长期适应并应对RRMS.
相关概念视频
Negative and Cognitive Symptoms of Schizophrenia
100
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
100
Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611
Psychosis: Goals of Pharmacotherapy
172
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
172
Psychological and Sociocultural Causes of Schizophrenia
146
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
146
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Long-term Depression
31.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.1K


